William D. Humphries is Director of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 2,538 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 19, 2023, when has been sold 2,538 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.54K
0% 3M change
0% 12M change
Total Value Held $0

William D. Humphries Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2023
BUY
Exercise of conversion of derivative security
-
2,538 Added 50.0%
2,538 Common Stock

Also insider at

BHC
Bausch Health Companies Inc. Healthcare
ACRS
Aclaris Therapeutics, Inc. Healthcare
CLSD
Clearside Biomedical, Inc. Healthcare
SSKN
STRATA Skin Sciences, Inc. Healthcare
WDH

William D. Humphries

Director
Wayne, PA

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Track Activities on PHAS